Vincent Hingot

Vincent Hingot is the President of the Drug Substance Division at Thermo Fisher Scientific since June 2022, where responsibilities include driving financial and market performance while leading a diverse team of General Managers and functional leaders. Previously, Vincent held several senior leadership roles at Sanofi Pasteur, most notably as Senior Vice President for Global Industrial Operations Manufacturing & Supply, overseeing the production of 1 billion vaccine doses annually and managing a global network of 12 industrial sites. Earlier experience includes positions at GlaxoSmithKline Biologicals, where Vincent served as Vice President of Industrial Operations and managed large-scale vaccine production, and in various roles at SmithKline Beecham and other companies focused on biotechnology and manufacturing processes. Vincent holds a Master of Engineering degree in Biotechnology and completed additional training in industrial operations.